Open AccessP946: A PHASE I/II SINGLE ARM STUDY OF BELANTAMAB MAFODOTIN, CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: AMARC 19‐02 BELACARD STUDY.
Author(s) -
Lasica M.,
Spencer A.,
Campbell P.,
WallingtonGates C.,
Wong Doo N.,
Janowski W.,
McCaughan G.,
Puliyayil A.,
Yuen F.,
Le K.,
Reynolds J.,
Quach H.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846652.51254.ac
Subject(s) - carfilzomib , medicine , tolerability , dexamethasone , multiple myeloma , adverse effect , lenalidomide , phases of clinical research , progressive disease , gastroenterology , oncology , surgery , toxicity , chemotherapy